CD34 and acute myeloid leukemia: To substantiate these findings, the colony-forming potential of AML (n = 5), HR-MDS (n = 5) and healthy (n = 5) BMMC-derived CD34+ cells after treatment with AFM28 and allogeneic NK cells was assessed.